Plain-English translation of NCT06969833 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a research study that follows patients with advanced ovarian, peritoneal, or fallopian tube cancer. Researchers will collect a one-time blood sample and keep track of leftover tissue samples from your routine care. Over two years, you'll also answer questions about how you're feeling, your quality of life, and any anxiety — helping doctors understand what factors affect survival and treatment outcomes in these cancers.
Doctors want to better understand why some patients with these cancers survive longer than others, and how treatment affects your quality of life. By studying blood and tissue samples alongside your health information, researchers hope to find new ways to predict outcomes and improve care.
You likely qualify if…
You likely don't qualify if…
You'll provide one blood sample when you join the study. Doctors will also collect leftover tissue and fluid samples from your routine cancer care for the next two years. You'll fill out brief questionnaires about your quality of life and mood several times: after you start treatment, after 3 and 6 treatment cycles, and then every three months for up to two years. These can be completed on paper or digitally, whichever you prefer.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
France